Australia’s medical cannabis industry remained in robust health during the first half of 2023, according to data from the Therapeutic Goods Administration (TGA), the country’s medicine and therapeutic regulatory agency.
Medical cannabis approvals through an Authorized Prescriber (AP) have continued to grow rapidly so far this year.
ADVERTISEMENT
Medical cannabis approvals through an AP reached approximately 304,000 in the first half, up more than 120% over the same period last year, when there were 137,000 AP approvals.
One of the reasons approvals are rising is due to the increasing number of authorized prescribers, who are allowed to prescribe certain cannabis product formats in five respective categories.
The aggregate number of medical practitioners approved under the AP scheme rose from 175 in 2020, to 636 in 2021, and to 1,454 in 2022.
By category, Authorized Prescriber prescriptions so far this year are:
At least 98% CBD (roughly
Read full article on Marijuana Business Daily
